FREE Webinar - Advances in High Throughput Formulation Screening - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Untitled Document

FREE Webinar - Advances in High Throughput Formulation Screening

Wednesday 20th November 2013 at 3 pm GMT, 4 pm CET, 10 am EST

In response to the challenges of new product formats and increased regulatory scrutiny, the early developability of biotherapeutic candidates based on stability and formulation characteristics is becoming ever more important. This interactive webinar, brought to you by Avacta Analytical and Synthon Biopharmaceuticals, will address the themes and challenges in this area.

The webinar will demonstrate how high throughput protein thermal stability analysis is widely used as a predictive tool to accelerate formulation development and candidate selection, or to optimise processing conditions downstream. It will focus on the formulation of a monoclonal antibody and the capabilities of high throughput screening to predict degradation, characterise stability and enhance workflows, as well as offering a case study in an industrial setting.

Click here to learn more and to register.

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
FindPharma Custom Search

Click here